GlassScriptPhysician profile
Lisa K Thomas
NPI 1942480785
$483.96
in general payments reported to CMS, 2019-2025
11 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $38.02 · 2023: $204 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.36 | 2021-2023 | Ofev |
| Mayne Pharma Commercial LLC | $119.73 | 2025 | Annovera, Nextstellis |
| Mylan Specialty L.P. | $63.41 | 2021-2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $35.44 | 2023 | Breztri |
| Genzyme Corporation | $22.52 | 2023 | |
| Jazz Pharmaceuticals INC. | $22.45 | 2023 | |
| Mallinckrodt Hospital Products INC. | $20.79 | 2023 | Acthar |
| Inogen, INC. | $19.70 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.53 | 2022 | |
| Inspire Medical Systems, INC. | $15.64 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $14.39 | 2023 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.